Radial Extracorporeal Shock Wave Therapy as a Novel Agent for Benign Prostatic Hyperplasia Refractory to Current Medical Therapy

Zhang, Dai; Wang, Yunlei; Gong, Daxin; Zhang, Zhao-Xuan; Yu, Xiaotong; Ma, Yuliang

doi:10.1177/1557988319831899

Cited by 13 publications

(18 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Because of these beneficial characteristics, ESWT has been a therapeutic option for the treatment of many musculoskeletal diseases ( 6 , 7 ), including plantar fasciitis ( 8 – 10 ), calcific shoulder tendinopathy ( 11 ), tennis elbow ( 12 ), trigger finger ( 13 ), knee osteoarthritis ( 14 ), and bone non-union ( 15 – 17 ). ESWT has also been utilized to treat wounds ( 18 – 21 ), urological diseases ( 22 – 24 ), and male erectile rejuvenation ( 25 ).…”

Section: Introductionmentioning

confidence: 99%

Application of extracorporeal shock wave therapy in nervous system diseases: A review

Guo

Hai

2022

Front. Neurol.

View full text Add to dashboard Cite

Neurological disorders are one of the leading causes of morbidity and mortality worldwide, and their therapeutic options remain limited. Recent animal and clinical studies have shown the potential of extracorporeal shock wave therapy (ESWT) as an innovative, safe, and cost-effective option to treat neurological disorders. Moreover, the cellular and molecular mechanism of ESWT has been proposed to better understand the regeneration and repairment of neurological disorders by ESWT. In this review, we discuss the principles of ESWT, the animal and clinical studies involving the use of ESWT to treat central and peripheral nervous system diseases, and the proposed cellular and molecular mechanism of ESWT. We also discuss the challenges encountered when applying ESWT to the human brain and spinal cord and the new potential applications of ESWT in treating neurological disorders.

show abstract

Section: Introductionmentioning

confidence: 99%

Application of extracorporeal shock wave therapy in nervous system diseases: A review

Guo

Hai

2022

Front. Neurol.

View full text Add to dashboard Cite

show abstract

“…In a meta-analysis(70), ESWT signi cantly reduced the proportion of penile plaques and relieving pain in PD patients. Moreover, in Zhang's study (71), ESWT was testi ed to be effective in BPH patients who did not respond to a drug or surgical treatment. In 3 months after treatment in patients with maximum urinary ow rate increases, the bladder residual urine volume decreases.…”

Section: Discussionmentioning

confidence: 99%

Global Trends in Research on extracorporeal shock wave therapy(ESWT) from 2000 to 2021

Zhang¹,

Ma²

2022

Preprint

View full text Add to dashboard Cite

Background: This study intended to analyze the application of extracorporeal shock wave therapy in medicine and to evaluate the quality of related literature. Methods: All publications were extracted from 2000 to 2021 from the Web of Science Core Collection (WoSCC). The literature characteristics were depicted by VOSviewer (version 1.6.15) and the online bibliometric website (http://bibliometric.com/). The future trends and hotspots were conducted by Bibliographic Item Co-occurrence Matrix Builder (version 2.0) and gCLUTO software. Results: We analyzed 1774 articles corresponding to the criteria for ESWT publications from 2000 to 2021. Most studies were conducted within the United States and China which besides have the most cooperation. The most published research institutions are Chang Gung University, Kaohsiung Chang Gung Memorial Hospital, and Kaohsiung Medical University. JOURNAL OF ORTHOPAEDIC RESEARCH, AMERICAN JOURNAL OF SPORTS MEDICINE, and JOURNAL OF SURGICAL RESEARCH are the top three most-cited journals. The keyword cluster analysis divides the 30 keywords with the highest frequency into 6 clusters. Conclusions: With the gradual increase of research on ESWT, we find that ESWT is used more and more extensively, such in musculoskeletal disease, bone delay union, neurological injury, andrology disorders, lymphedema, and so on. In addition, the mechanism is not destructive damage, as initially thought, but a restorative treatment. Furthermore, delayed union, cellulite, burn, and diabetic foot ulcers may be the future direction of scientific study.

show abstract

“…[ 15 ] Additionally, the body of literature on LSWT application for other indications within urology, keep on expanding over the years. Other indications include prostatic hyperplasia, [ 16 ] Peyronie's disease, [ 17 ] stress-induced urinary incontinence, [ 18 ] and overactive bladder. [ 19 ] More recently, interest in the utility of LSWT in CPPS is growing.…”

Section: Introductionmentioning

confidence: 99%

Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome patients with erectile dysfunction

Daneshwar¹,

Nordin²

2022

Medicine

View full text Add to dashboard Cite

Introduction: In this study, the efficacy of low intensity shock wave therapy (LSWT) in improving symptoms of chronic pelvic pain syndrome (CPPS) and erectile dysfunction (ED) was investigated. Methods: Men diagnosed with CPPS and ED (n = 50) were prescribed with LSWT. The LSWT was administered in 10 sessions over the course of 5 weeks at 3,000 pulses with .25 mJ/mm 2 energy flow and 5 Hz frequency. Outcome parameters were measured before and after LSWT. Results: Clinical symptoms related to CPPS and ED were measured using four validated questionnaires namely National Institute of Health Chronic Prostatitis Symptom Index (NIH-CPSI), the International Index of Erectile Function (IIEF), the International Prostate Symptom Score (IPSS), and Sexual Health Inventory for Men (SHIM). The effect of LSWT on each of the three domains of NIH-CPSI, namely Pain, Symptoms, and Quality of Life (QoL) were also analyzed. Uroflowmetry was measured to assess LSWT effect on urine voiding. The mean baseline CPPS symptoms on NIH-CPSI domains of pain, symptoms and QoL were 9.92 ± 5.72 (mean ± SD), 5.14 ± 14.5, and 8.02 ± 3.17, respectively. LSWT resulted in significant reduction of CPPS symptoms on all NIH-CPSI domains (Pain = .9 ± 1.37; Symptoms = .74 ± 1.03; QoL = 1.16 ± 1.78). The baseline means of CPPS symptoms on IIEF, IPSS, and SHIM were 45.42 ± 16.24, 24.68 ± 9.28, and 14.28 ± 6.02, respectively. LSWT significant improved CPPS symptoms on IIEF (49.48 ± 28.30) and IPSS (9.04 ± 7.01) but not on SHIM (16.02 ± 9.85). No statistically significant differences were observed with all uroflowmetry parameters. Conclusion: The current study demonstrated for the first time the safety and efficacy of LSWT administered in 10 sessions over 5 weeks in improving symptoms of CPPS and ED without causing any significant adverse effect to the patient.

show abstract

Radial Extracorporeal Shock Wave Therapy as a Novel Agent for Benign Prostatic Hyperplasia Refractory to Current Medical Therapy

Cited by 13 publications

References 33 publications

Application of extracorporeal shock wave therapy in nervous system diseases: A review

Application of extracorporeal shock wave therapy in nervous system diseases: A review

Global Trends in Research on extracorporeal shock wave therapy(ESWT) from 2000 to 2021

Low intensity extracorporeal shockwave therapy for chronic pelvic pain syndrome patients with erectile dysfunction

Contact Info

Product

Resources

About